Teclistamab Dosing in Responders: Modeling and Simulation Results from the MajesTEC-1 Study in Relapsed/Refractory Multiple Myeloma.

Yue Guo, Jin Niu, Natalia A Quijano Cardé,Liviawati Wu, Xin Miao, Shalla Hanson,Yaming Su, Carlos Pérez Ruixo,Deeksha Vishwamitra, Katherine Chastain,Mahesh N Samtani,Weirong Wang, Nahor Haddish-Berhane

Targeted oncology（2025）

Cited 0|Views0

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined